ASU Electronic Theses and Dissertations
This collection includes most of the ASU Theses and Dissertations from 2011 to present. ASU Theses and Dissertations are available in downloadable PDF format; however, a small percentage of items are under embargo. Information about the dissertations/theses includes degree information, committee members, an abstract, supporting data or media.
In addition to the electronic theses found in the ASU Digital Repository, ASU Theses and Dissertations can be found in the ASU Library Catalog.
Dissertations and Theses granted by Arizona State University are archived and made available through a joint effort of the ASU Graduate College and the ASU Libraries. For more information or questions about this collection contact or visit the Digital Repository ETD Library Guide or contact the ASU Graduate College at gradformat@asu.edu.
Displaying 1 - 5 of 5
Filtering by
- Creators: Shen, Wei
Description本文对中国制药企业并购溢价影响因素进行了研究，提出了对制药企业并购非常重要的两个新的影响因素：可生产药品批文和在研新药批文。本文以2011年1月—2019年12月间我国制药行业上市公司并购事件为样本，对在研新药和可生产药品批文的价值从四个维度度量：是否有在研新药和可生产药品批文；在研新药数量及可生产药品批文数量；根据创新药和仿制药两个类别进行细分；标的企业所拥有的在研新药和可生产药品批文的市场价值。论文发现药品批文对企业并购溢价的影响不是很显著。进一步的，本文探究了药品批文对主并企业的对被并购公司的估值的影响。实证结果表明，我国制药企业在并购估值时确实会考虑到在研新药和可生产药品批文的价值。本文还发现对于可生产药品来说，相对创新药，被并购公司持有的仿制药批文影响更显著。而对于在研新药来说，主并企业更看重在研的创新药，在研仿制药对并购估值的影响不大。最后，本文选取了两个代表性案例进一步分析和探讨药品批文对企业并购的影响。
ContributorsYe, Tao (Author) / Shen, Wei (Thesis advisor) / Chang, Chun (Thesis advisor) / Jiang, Zhan (Committee member) / Gu, Bin (Committee member) / Arizona State University (Publisher)
Created2022
Description
Mergers and acquisitions (M&As) have been playing a very significant role in the capital market. Many companies regard mergers and acquisitions as an important way for their business expansion and transformation. This paper begins with a review of literature on firm’s motivations of and outcomes in M&A, and followed by a critical examination of three case studies of actual M&A transactions based on the insights provided from the literature review. For each case study, a firm’s motivations and related managerial initiatives for M&A activities were examined, followed by an assessment of the firm’s post M&A performance results. This allows the study to discerns the insights of why and how a firm proceed in its M&A transactions from its strategic intent to its post M&A managerial actions. Collectively, the results show that the key drivers for a firm’s M&A successes rest on a firm’s abilities to manage the M&A activities consistent with its strategic intent (e.g., creating synergies or transformation through diversification) and followed by its post M&A integration efforts in achieving its strategic intent.
ContributorsYang, Zhibo (Author) / Pei, Ker-Wei (Thesis advisor) / Qian, Jun (Thesis advisor) / Shen, Wei (Committee member) / Jiang, Zhan (Committee member) / Arizona State University (Publisher)
Created2018
Description本文基于我国2006-2020年间IPO的上市公司上市当年的样本数据，研究了IPO视角下大股东控制权结构对上市公司盈利成长性的影响效应及影响机制。首先从机理上探讨了大股东控制权结构对上市公司盈利成长性的影响效应、中介机制和调节机制，并相应地构建了本文的三个研究假说。接下来，本文构建了证研究框架，具体包括模型构建、变量选择与数据选取三方面。最后，进行实证分析以验证本文的三个研究假说。通过实证研究，本文发现：首先，大股东控制权结构对上市公司盈利成长性存在显著影响，具体表现为大股东控制权中直接持股比重越高，上市公司盈利成长性则越低；第二，在大股东控制权中直接持股比重对上市公司盈利成长性的负影响中，存在着来自公司主营业务投入的负向中介效应，约占总影响效应的0.162；第三，在大股东控制权中直接持股比重对上市公司盈利成长性的负影响中，还存在着来自公司主营业务利润的负向调节作用，并且在考虑调节作用后，大股东控制权中直接持股比重对上市公司盈利成长性的直接影响不再显著；第四，大股东控制权中直接持股比重对上市公司盈利成长性的影响效应及其具体作用机制主要存在于制造业公司中，而在非制造业公司中并不明显。
最后，基于研究结论，本文从上市公司治理的角度提出两点提升公司盈利成长性的对策建议：一是上市公司尤其是制造业上市公司，在经营管理中应适度引入外部投资机构；二是上市公司在经营管理过程中应注重于主营业务的发展。
ContributorsLuo, Xuan (Author) / Shen, Wei (Thesis advisor) / Cheng, Shijun (Thesis advisor) / Jiang, Zhan (Committee member) / Arizona State University (Publisher)
Created2023
Description
This study investigates the performance effects of cross-industry mergers and acquisitions (M&A) using a sample of firms listed in China’s Growth Entrepreses Market (GEM). Compared to firms listed in the Shanghai and Shenzhen Stock Exchanges, firms listed in the GEM are much smaller and tend to derive the majority of their revenues from a single industry. I first analyze the motives for firms listed in the GEM to engage in M&As and propose a set of factors that may influence their likelihood of M&A activities. Using data on 55 cross-industry M&As between January 1, 2012 and December 31, 2016, I find that investor generally responded positively in short-term, as indicated by the positive accumulated abonormal returns over the first five trading days following the announcements. Meanwhile, I found no evidence that investors benefited from cross-industry M&As in long-term over three years after the event. Further analysis suggests that the short-term effects of cross-industry M&As by GEM listed firms were influenced by the target firm’s market valuation, whether the M&A was paid by cash, the amount of the payment, and the degree of difference between the acquiring firm’s and the target firm’s industries. These findings have important implications for the investors and senior executives of firms listed in the GEM.
ContributorsZhou, Wei (Author) / Shen, Wei (Thesis advisor) / Yu, Xiaoyun (Thesis advisor) / Jiang, Zhan (Committee member) / Arizona State University (Publisher)
Created2018
Description
On January 30, 2019, the China Securities Regulatory Commission issued the Implementation Opinions on the Establishment of the Science and Technology Innovation Board on the Shanghai Stock Exchange and the Pilot Registration-based System, announcing the establishment of a new Science and Technology Innovation Board(STAR). The STAR Market is an important measure in China's capital market reform, aiming to promote the transformation of China's economy from a stage of rapid growth to a stage of high-quality development. The companies listed on the Science and Technology Innovation Board are mainly scientific and technological innovation enterprises that are at the forefront of the world's science and technology, the main battlefield of the economy, and the major needs of the country, in line with the national strategy, breaking through key core technologies, and with high market recognition. Since its launch on July 22, 2019, to May, 15, 2023, there are 522 companies have been listed on the STAR Market, with a total market capitalization of more than RMB 7 trillion. The successful listing of these enterprises will provide strong support for the deep integration of China's high-tech industries and strategic emerging industries.This paper analyzes the influencing factors of IPO listing pricing on the STAR Market, and studies 1478 companies listed on the three listing platforms of the STAR Market, ChiNext and Hong Kong stocks. Through descriptive statistical analysis and multivariate regression model, the influencing factors of the 1st day and the 20th day were empirically studied. The results of the study will provide a pricing reference for
ii
listed companies in the future, and provide a reference for policymakers to meet the expectations of the new regulatory reforms.
Through analysis of multiple factors includes but not limited as the NR,IPE, LEAD, ISCA, T10, AOL, BC, STL, RDI, CAGR, DTOR, these influencing factors have an important impact on the IPO of the STAR Market.
ContributorsHuang, Danyang (Author) / Shen, Wei (Thesis advisor) / Cheng, Shijun (Thesis advisor) / Jiang, Zhan (Committee member) / Arizona State University (Publisher)
Created2024